Brookstone Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$842K Buy
9,227
+644
+8% +$58.7K 0.01% 609
2025
Q1
$971K Buy
8,583
+2
+0% +$226 0.01% 563
2024
Q4
$906K Buy
8,581
+2,193
+34% +$232K 0.01% 557
2024
Q3
$690K Buy
6,388
+322
+5% +$34.8K 0.01% 608
2024
Q2
$674K Sell
6,066
-528
-8% -$58.6K 0.01% 580
2024
Q1
$870K Sell
6,594
-122
-2% -$16.1K 0.02% 519
2023
Q4
$817K Buy
6,716
+361
+6% +$43.9K 0.02% 498
2023
Q3
$666K Sell
6,355
-32,571
-84% -$3.41M 0.01% 511
2023
Q2
$5.48M Buy
38,926
+8,115
+26% +$1.14M 0.11% 184
2023
Q1
$4.11M Buy
30,811
+7,541
+32% +$1.01M 0.08% 219
2022
Q4
$2.93M Buy
23,270
+4,732
+26% +$595K 0.06% 241
2022
Q3
$1.99M Buy
18,538
+5,429
+41% +$581K 0.05% 286
2022
Q2
$1.38M Buy
13,109
+1,837
+16% +$194K 0.03% 350
2022
Q1
$1.43M Sell
11,272
-2,084
-16% -$264K 0.03% 334
2021
Q4
$1.66M Buy
13,356
+6,477
+94% +$806K 0.03% 298
2021
Q3
$954K Buy
6,879
+2,228
+48% +$309K 0.02% 388
2021
Q2
$709K Buy
4,651
+113
+2% +$17.2K 0.01% 422
2021
Q1
$705K Buy
4,538
+47
+1% +$7.3K 0.03% 297
2020
Q4
$672K Buy
4,491
+87
+2% +$13K 0.03% 294
2020
Q3
$582K Sell
4,404
-319
-7% -$42.2K 0.03% 250
2020
Q2
$547K Buy
4,723
+242
+5% +$28K 0.03% 225
2020
Q1
$440K Buy
4,481
+4
+0.1% +$393 0.03% 222
2019
Q4
$651K Buy
4,477
+78
+2% +$11.3K 0.03% 248
2019
Q3
$586K Buy
+4,399
New +$586K 0.03% 243
2015
Q4
Sell
-167
Closed -$15K 897
2015
Q3
$15K Sell
167
-41
-20% -$3.68K ﹤0.01% 919
2015
Q2
$22K Buy
+208
New +$22K ﹤0.01% 820